These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 32157282)

  • 1. Maternal Secretor Status Affects Oral Rotavirus Vaccine Response in Breastfed Infants in Bangladesh.
    Williams FB; Kader A; Colgate ER; Dickson DM; Carmolli M; Uddin MI; Sharmin S; Islam S; Bhuiyan TR; Alam M; Nayak U; Mychaleckyj JC; Petri WA; Haque R; Qadri F; Kirkpatrick BD; Lee B
    J Infect Dis; 2021 Oct; 224(7):1147-1151. PubMed ID: 32157282
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Histo-Blood Group Antigen Phenotype Determines Susceptibility to Genotype-Specific Rotavirus Infections and Impacts Measures of Rotavirus Vaccine Efficacy.
    Lee B; Dickson DM; deCamp AC; Ross Colgate E; Diehl SA; Uddin MI; Sharmin S; Islam S; Bhuiyan TR; Alam M; Nayak U; Mychaleckyj JC; Taniuchi M; Petri WA; Haque R; Qadri F; Kirkpatrick BD
    J Infect Dis; 2018 Apr; 217(9):1399-1407. PubMed ID: 29390150
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rotavirus-Specific Immunoglobulin A Responses Are Impaired and Serve as a Suboptimal Correlate of Protection Among Infants in Bangladesh.
    Lee B; Carmolli M; Dickson DM; Colgate ER; Diehl SA; Uddin MI; Islam S; Hossain M; Rafique TA; Bhuiyan TR; Alam M; Nayak U; Mychaleckyj JC; McNeal MM; Petri WA; Qadri F; Haque R; Kirkpatrick BD
    Clin Infect Dis; 2018 Jul; 67(2):186-192. PubMed ID: 29394355
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rotavirus Vaccine Take in Infants Is Associated With Secretor Status.
    Armah GE; Cortese MM; Dennis FE; Yu Y; Morrow AL; McNeal MM; Lewis KDC; Awuni DA; Armachie J; Parashar UD
    J Infect Dis; 2019 Feb; 219(5):746-749. PubMed ID: 30357332
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevaccination Rotavirus Serum IgG and IgA Are Associated With Lower Immunogenicity of Live, Oral Human Rotavirus Vaccine in South African Infants.
    Moon SS; Groome MJ; Velasquez DE; Parashar UD; Jones S; Koen A; van Niekerk N; Jiang B; Madhi SA
    Clin Infect Dis; 2016 Jan; 62(2):157-65. PubMed ID: 26400993
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of Maternal Immunity with Rotavirus Vaccine Immunogenicity in Zambian Infants.
    Chilengi R; Simuyandi M; Beach L; Mwila K; Becker-Dreps S; Emperador DM; Velasquez DE; Bosomprah S; Jiang B
    PLoS One; 2016; 11(3):e0150100. PubMed ID: 26974432
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of withholding breastfeeding on the immune response to a live oral rotavirus vaccine in North Indian infants.
    Rongsen-Chandola T; Strand TA; Goyal N; Flem E; Rathore SS; Arya A; Winje BA; Lazarus R; Shanmugasundaram E; Babji S; Sommerfelt H; Vainio K; Kang G; Bhandari N
    Vaccine; 2014 Aug; 32 Suppl 1():A134-9. PubMed ID: 25091668
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of increased inoculum on oral rotavirus vaccine take among infants in Dhaka, Bangladesh: A double-blind, parallel group, randomized, controlled trial.
    Lee B; Dickson DM; Alam M; Afreen S; Kader A; Afrin F; Ferdousi T; Damon CF; Gullickson SK; McNeal MM; Bak DM; Tolba M; Carmolli MP; Taniuchi M; Haque R; Kirkpatrick BD
    Vaccine; 2020 Jan; 38(1):90-99. PubMed ID: 31607603
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of Infant and Maternal Secretor Status on Rotavirus Vaccine Take-An Overview.
    Sharma S; Nordgren J
    Viruses; 2021 Jun; 13(6):. PubMed ID: 34198720
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Secretor and Salivary ABO Blood Group Antigen Status Predict Rotavirus Vaccine Take in Infants.
    Kazi AM; Cortese MM; Yu Y; Lopman B; Morrow AL; Fleming JA; McNeal MM; Steele AD; Parashar UD; Zaidi AKM; Ali A
    J Infect Dis; 2017 Mar; 215(5):786-789. PubMed ID: 28329092
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Head-to-head comparison of the immunogenicity of RotaTeq and Rotarix rotavirus vaccines and factors associated with seroresponse in infants in Bangladesh: a randomised, controlled, open-label, parallel, phase 4 trial.
    Velasquez-Portocarrero DE; Wang X; Cortese MM; Snider CJ; Anand A; Costantini VP; Yunus M; Aziz AB; Haque W; Parashar U; Sisay Z; Soeters HM; Hyde TB; Jiang B; Zaman K
    Lancet Infect Dis; 2022 Nov; 22(11):1606-1616. PubMed ID: 35961362
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomized, open-labelled, non-inferiority phase 4 clinical trial to evaluate the immunogenicity and safety of the live, attenuated, oral rotavirus vaccine, ROTAVAC® in comparison with a licensed rotavirus vaccine in healthy infants.
    Ella R; Babji S; Ciarlet M; Blackwelder WC; Vadrevu KM
    Vaccine; 2019 Jul; 37(31):4407-4413. PubMed ID: 31178377
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of withholding breastfeeding at the time of vaccination on the immunogenicity of oral rotavirus vaccine--a randomized trial.
    Ali A; Kazi AM; Cortese MM; Fleming JA; Moon S; Parashar UD; Jiang B; McNeal MM; Steele D; Bhutta Z; Zaidi AK
    PLoS One; 2015; 10(6):e0127622. PubMed ID: 26035743
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Breastfeeding linked to the reduction of both rotavirus shedding and IgA levels after Rotarix® immunization in Mexican infants.
    Bautista-Marquez A; Velasquez DE; Esparza-Aguilar M; Luna-Cruz M; Ruiz-Moran T; Sugata K; Jiang B; Parashar U; Patel M; Richardson V
    Vaccine; 2016 Oct; 34(44):5284-5289. PubMed ID: 27663670
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rotavirus specific maternal antibodies and immune response to RV3-BB neonatal rotavirus vaccine in New Zealand.
    Chen MY; Kirkwood CD; Bines J; Cowley D; Pavlic D; Lee KJ; Orsini F; Watts E; Barnes G; Danchin M
    Hum Vaccin Immunother; 2017 May; 13(5):1126-1135. PubMed ID: 28059609
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlates of Rotavirus Vaccine Shedding and Seroconversion in a US Cohort of Healthy Infants.
    Burke RM; Payne DC; McNeal M; Conrey SC; Burrell AR; Mattison CP; Casey-Moore MC; Mijatovic-Rustempasic S; Gautam R; Esona MD; Thorman AW; Bowen MD; Parashar UD; Tate JE; Morrow AL; Staat MA
    J Infect Dis; 2024 Sep; 230(3):754-762. PubMed ID: 38330312
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of maternal antibodies and microbiota development on the immunogenicity of oral rotavirus vaccine in African, Indian, and European infants.
    Parker EPK; Bronowski C; Sindhu KNC; Babji S; Benny B; Carmona-Vicente N; Chasweka N; Chinyama E; Cunliffe NA; Dube Q; Giri S; Grassly NC; Gunasekaran A; Howarth D; Immanuel S; Jere KC; Kampmann B; Lowe J; Mandolo J; Praharaj I; Rani BS; Silas S; Srinivasan VK; Turner M; Venugopal S; Verghese VP; Darby AC; Kang G; Iturriza-Gómara M
    Nat Commun; 2021 Dec; 12(1):7288. PubMed ID: 34911947
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Maternal antibody interference contributes to reduced rotavirus vaccine efficacy in developing countries.
    Otero CE; Langel SN; Blasi M; Permar SR
    PLoS Pathog; 2020 Nov; 16(11):e1009010. PubMed ID: 33211756
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of breastfeeding on immunogenicity of oral live-attenuated human rotavirus vaccine: a randomized trial in HIV-uninfected infants in Soweto, South Africa.
    Groome MJ; Moon SS; Velasquez D; Jones S; Koen A; van Niekerk N; Jiang B; Parashar UD; Madhi SA
    Bull World Health Organ; 2014 Apr; 92(4):238-45. PubMed ID: 24700991
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reactogenicity and safety of a liquid human rotavirus vaccine (RIX4414) in healthy adults, children and infants in China: randomized, double-blind, placebo-controlled Phase I studies.
    Li RC; Li YP; Mo ZJ; Luo D; Huang T; Kong JL; Wang LH; Song NS; Liu A; Zhang H; Liao X; Karkada N; Han HH
    Hum Vaccin Immunother; 2013 Aug; 9(8):1638-42. PubMed ID: 23807360
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.